LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

Search

Pfizer

Geschlossen

BrancheGesundheitswesen

24.9 -2.16

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

24.72

Max

25.49

Schlüsselkennzahlen

By Trading Economics

Einkommen

623M

3.6B

Verkäufe

2B

17B

KGV

Branchendurchschnitt

14.18

105.69

EPS

0.87

Dividendenrendite

6.96

Gewinnspanne

21.322

Angestellte

81,000

EBITDA

325M

5.6B

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+14.26% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

6.96%

2.37%

Nächste Dividendenausschüttung

1. Dez. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-1.5B

139B

Vorheriger Eröffnungskurs

27.06

Vorheriger Schlusskurs

24.9

Nachrichtenstimmung

By Acuity

40%

60%

156 / 374 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

Pfizer Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

13. Nov. 2025, 17:39 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer Completes Acquisition of Metsera

10. Nov. 2025, 13:08 UTC

Wichtige Markttreiber
Akquisitionen, Fusionen, Übernahmen

Metsera Shares Fall Premarket as Novo Throws in Towel on Bidding War

10. Nov. 2025, 09:41 UTC

Akquisitionen, Fusionen, Übernahmen

Novo Nordisk Shares Rise After Withdrawal of Metsera Takeover Battle

17. Nov. 2025, 18:20 UTC

Akquisitionen, Fusionen, Übernahmen

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion -- Barrons.com

14. Nov. 2025, 12:22 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Pharma Sector Becoming Bidding Battlefield -- Market Talk

13. Nov. 2025, 16:26 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer Completes Acquisition Of Metsera >PFE

10. Nov. 2025, 16:35 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Pfizer CEO Confident Metsera Therapies Will Get Approval -- Market Talk

10. Nov. 2025, 16:26 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Pfizer CEO: Metsera Has Exciting Weight-Loss Portfolio -- Market Talk

10. Nov. 2025, 15:36 UTC

Akquisitionen, Fusionen, Übernahmen

What's Next for Novo Nordisk? -- WSJ

10. Nov. 2025, 14:05 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Pfizer Will See Big Benefits from Metsera Acquisition -- Market Talk

10. Nov. 2025, 12:33 UTC

Akquisitionen, Fusionen, Übernahmen

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, Monday.com, CoreWeave, and More -- Barrons.com

10. Nov. 2025, 12:32 UTC

Akquisitionen, Fusionen, Übernahmen

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, Monday.com, CoreWeave, and More -- Barrons.com

10. Nov. 2025, 10:45 UTC

Akquisitionen, Fusionen, Übernahmen

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, CoreWeave, and More -- Barrons.com

10. Nov. 2025, 10:34 UTC

Akquisitionen, Fusionen, Übernahmen

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, CoreWeave, and More -- Barrons.com

10. Nov. 2025, 10:32 UTC

Heiße Aktien

Stocks to Watch Monday: Metsera, Novo Nordisk, Nvidia, Tyson Foods -- WSJ

10. Nov. 2025, 09:26 UTC

Akquisitionen, Fusionen, Übernahmen

Novo Nordisk Shares Rise After Withdrawal From Metsera Takeover Battle

8. Nov. 2025, 13:10 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- Update

8. Nov. 2025, 03:50 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- 4th Update

8. Nov. 2025, 03:41 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- WSJ

8. Nov. 2025, 03:07 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer and Metsera Reach Deal Worth Up to $10 Billion -- WSJ

7. Nov. 2025, 13:26 UTC

Akquisitionen, Fusionen, Übernahmen

Correction to This Unlikely Duo Is Developing a Weight-Loss Pill. Big Pharma Is Obsessed. Article -- WSJ

7. Nov. 2025, 10:30 UTC

Akquisitionen, Fusionen, Übernahmen

This Unlikely Duo Is Developing a Weight-Loss Pill. Big Pharma Is Obsessed. -- WSJ

6. Nov. 2025, 20:02 UTC

Akquisitionen, Fusionen, Übernahmen

Biotech M&A Deals Are Trickier Than They Look. Watch the Milestone Payments. -- Barrons.com

6. Nov. 2025, 16:16 UTC

Ergebnisse

Moderna's Quarter Wasn't As Bad as It Could Have Been. The Stock is Up -- Barrons.com

6. Nov. 2025, 12:29 UTC

Ergebnisse

Moderna Swings to a Loss. The Stock Jumps Anyway. -- Barrons.com

6. Nov. 2025, 12:15 UTC

Ergebnisse

Moderna Swings to a Loss. The Stock Jumps Anyway. -- Barrons.com

6. Nov. 2025, 00:24 UTC

Akquisitionen, Fusionen, Übernahmen

Metsera: Pfizer Has Reiterated It Will Continue to Litigate >MTSR

6. Nov. 2025, 00:24 UTC

Akquisitionen, Fusionen, Übernahmen

Metsera: Board of Directors Will Continue to Stand Firm on Behalf of Shareholders, Patients >MTSR

6. Nov. 2025, 00:24 UTC

Akquisitionen, Fusionen, Übernahmen

Metsera: Gratified by Court Decision to Deny Pfizer's Request for Temporary Restraining Order to Block Board From Acting in Shareholders' Best Interests >MTSR

6. Nov. 2025, 00:22 UTC

Akquisitionen, Fusionen, Übernahmen

Metsera Issues Statement in Response to Pfizer Litigation Ruling

Peer-Vergleich

Kursveränderung

Pfizer Prognose

Kursziel

By TipRanks

14.26% Vorteil

12-Monats-Prognose

Durchschnitt 29.08 USD  14.26%

Hoch 34 USD

Tief 24 USD

Basierend auf 15 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Pfizer – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

15 ratings

4

Buy

10

Halten

1

Sell

Technischer Score

By Trading Central

22.855 / 23.85Unterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Bearish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

156 / 374 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
help-icon Live chat